NSCLCnon-small cell lung cancerRilvegostomig
…tomig, an anti-PD-1/ TIGIT bispecific, for CPI-naïve metastatic NSCLC with PD-L1 1-49% or ≥50%. J Thorac Oncol. 2024;19:10,S33.…
189articles mentioning diseases
777disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: NSCLC ×
NSCLC
This disease is selected. Its supporting articles are shown below.
Articles mentioning NSCLC
189 articles · page 4 of 16non-small cell lung cancerNSCLCRilvegostomigHBS regulatory board
…g has demonstrated encouraging results in a Phase I/II trial of non-small cell lung cancer (NSCLC) ( NCT04995523), and is currently being evaluated in mul…
NSCLCnon-small cell lung cancerNational Center for Cancer Care and ResearchHamad Medical Corporation
…tember 2021-June 2023. Sera from 31 locally advanced/metastatic NSCLC patients, eligible for anti-PD-1/PD-L1 or combined chemoimmunot…
NSCLCNSCLC-associatedhuman non-small cell lung cancernivolumabipilimumab
…or T-cell immunity in NSCLC.Methods To develop a mouse model of NSCLC expressing both T- and B-cell neoantigens, we transduced 344SQ …
NSCLCadvanced or metastatic squamous cell non-small cell lung cancerdigital, short-form, case-based medical education
…o-IO treatment of patients with advanced or metastatic squamous NSCLC without molecular alterations.…
Lung cancerNSCLCNivolumabIpilimumab
…Background Lung cancer is the leading cause of cancer-related deaths worldwide, and no…
non-small cell lung carcinomaNSCLCnon-small-cell lung cancerJ Immunother Canceranti-PD1 immunotherapyneoadjuvant anti-PD-1-based therapy
…fector T-cells and predict outcomes in patients with resectable non-small cell lung carcinoma (NSCLC) receiving neoadjuvant anti-PD-1-based therapy. J Immuno…
NSCLCnon-small cell lung cancerlung adenocarcinoma
…s was a high-risk factor for cancer-related death in metastatic NSCLC.Conclusions The mutational burden, PD-L1 expression and IC infi…
NSCLCnon-small cell lung canceradenocarcinomasquamous cell carcinoma
… showed a higher Gini index. While in the operated patient with NSCLC cohort, TCR clonality was not prognostic, in an immune checkpoi…
NSCLCnon-small cell lung cancerDanish Lung Cancer RegistrySurgical resectionrehabilitationphysical exercise training
…nt.Conclusions QoL and symptoms were impaired 6–12 months after NSCLC surgery, and the current level did not seem to be related to ha…
non-small cell lung cancerNSCLCpublicly funded healthcare systemNational Health ServiceNHSnovel therapeuticsEnglish national cancer registrySystemic Anti-Cancer Therapy database
…Background Sociodemographic inequalities impact patients with non-small cell lung cancer (NSCLC). Advances in novel therapeutics have increased treatmen…